AEROSURGICAL

AeroSurgical Limited is a surgical device company that incorporates state of the art aerosol technology to form the basis of its proprietary AeroSurge Platform which efficiently delivers therapeutics to affected areas in surgery. Following several years of research and development, AeroSurgical is preparing to undertake a Phase II clinical trial in Europe as the next step towards commercialization of AeroSurge PR1, the company's lead product candidate. AeroSurge PR1 will address post-operative laparoscopic pain by delivering a local anesthetic into the peritoneal cavity during surgery. The company's sophisticated technology will allow surgeons to effectively address post-operative pain before the pain begins with expected improvement in patient outcomes including earlier ambulation, reduction in opiate use and the potential for a shorter hospital stay for non-ambulatory procedures.

Also known as: AeroSurgical Limited, AeroSurgical Ltd.